This page presents all the consortium members of SAMIRA-PrISMA.
- The Netherlands, National Institute for Public Health and the Environment (RIVM), Coordinator;
- Finland, Radiation and Nuclear Safety Authority (STUK);
- Finland, Ministry of Social Affairs and Health (MSAH).
- Sweden, Medical Products Agency (MPA);
- Sweden, Radiation Safety Authority (SSM);
- Norway, Norwegian Radiation and Nuclear Safety Authority (DSA);
- Norway, Norwegian Directorate of Health (HDIR);
- Spain, Catalan Institute of Oncology (ICO);
- Spain, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS);
- Lithuania, Hospital of Lithuanian University of Health Sciences Kauno klinikos (LSMULKK);
- Italy, Istituto Superiore di Sanità (ISS);
- Italy, Policlinico Universitario Agostino Gemelli IRCCS (FPG-UCSC);
- Hungary, National Center for Public Health and Pharmacy (NCPHP);
- Denmark, Danish Health Authority (Sundhedsstyrelsen, (SST);
- Croatia, Klinicka Bolnica Dubrava – Dubrava University Hospital (DUH);
- Croatia, Croatian Medical Physics Association (CROMPA);
- Portugal, Directorate General of Health (DGS);
- Ireland, Health Information and Quality Authority (HIQA).